Adial Pharmaceuticals (ADIL) Q4 2025 Earnings

14NovConfirmed
Q1 2025
Q2 2025
Q3 2025
Q4 2025
-3.5
-2.39
-1.29
-0.18

Details

Expected EPS
-3.5
Actual EPS
-2
Surprise EPS
1.5
Surprise Percent
+42.86%

Description

Adial Pharmaceuticals (ADIL) has reported earnings of -2 per share for Q4 2025.

0 Comments

Share your thoughts